Role of Pericapsular Nerve Block Using Dexmedetomidine and Bupivacaine in Improving the Outcome of Patients Undergoing Hip Surgery Under Spinal Anesthesia

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 10, 2024

Primary Completion Date

June 10, 2025

Study Completion Date

June 10, 2025

Conditions
Pain During Spinal Positioning
Interventions
DRUG

Dexmedetomidin

The PENG block will be performed using a mixture of 0.25% bupivacaine (1.25 to 2.5 mg/kg.) combined with dexmedetomidine at a dose of 1.25 mcg/kg

DRUG

Bupivacain

a typical dose of 0.5% hyperbaric bupivacaine ranges from 0.1 to 0.15 mg/kg (2 to 3 mL), depending on the patient's height and clinical condition. Lower doses are used for shorter or elderly patients, while taller patients may require higher doses

Trial Locations (1)

11111

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT07149168 - Role of Pericapsular Nerve Block Using Dexmedetomidine and Bupivacaine in Improving the Outcome of Patients Undergoing Hip Surgery Under Spinal Anesthesia | Biotech Hunter | Biotech Hunter